Biologic breast implant
The present disclosure provides tissue products produced from adipose tissues, as well as methods for producing such tissue products. The tissue products can include acellular tissue matrices for treatment of a breast.
1. A method for producing a tissue product, comprising the steps of:
selecting an adipose tissue;
treating the tissue to remove substantially all cellular material from the tissue;
suspending the tissue in a liquid to form a suspension with a 2-4% by weight solid content; and
freezing and drying the suspension to form a porous sponge.
2. The method of claim 1 , further comprising cross-linking the porous sponge.
3. The method of claim 2 , wherein cross-linking is performed using a dehydrothermal process.
4. The method of claim 3 , further comprising performing a chemical cross-linking step.
5. The method of claim 1 , wherein the porous sponge comprises a desired thickness at least in the thickest part of the sponge, the desired thickness exceeding 10.0 cm.
6. The method of claim 1 , further comprising adding the suspension to a mold.
7. The method of claim 6 , wherein the mold is in the shape of a round or a tear-drop breast implant.
8. The method of claim 4 , wherein the chemical cross-linking step includes at least one of glutaraldehyde, genepin, carbodiimides, and diisocyanates.
9. The method of claim 4 , wherein cross-linking includes heating the porous sponge.
10. The method of claim 9 , wherein the porous sponge is heated in a vacuum.
11. The method of claim 10 , wherein the porous sponge is heated to a range of 70° C. to 120° C.
12. The method of claim 4 , wherein the porous sponge is cross-linked such that the material maintains a stable three-dimensional structure when contacted with an aqueous environment.
13. The method of claim 12 , wherein the aqueous environment is a mammalian body.
14. A tissue product, comprising:
a breast implant, the implant comprising a construct of acellular adipose tissue matrix including particulate acellular adipose tissue matrix that has been formed into a suspension, dried, and stabilized, wherein the suspension comprises 2-4% by weight solid content, and wherein the implant measures at least 5 cm in at least one dimension.
15. The tissue product of claim 14 , wherein the implant measures at least 8 cm in at least one dimension.
16. The tissue product of claim 14 , wherein the implant is in the form of a rounded breast implant.
17. The tissue product of claim 14 , wherein the implant is in the form of a tear-drop shaped breast implant.
18. The tissue product of claim 14 , wherein the implant is produced by a process comprising:
selecting an adipose tissue;
treating the tissue to remove substantially all cellular material from the tissue;
suspending the tissue in a liquid to form a suspension with a 2-4% by weight solid content; and
freezing and drying the suspension to form a porous sponge.
19. The tissue product of claim 14 , wherein the suspension is stabilized by cross-linking.